glp 1 in perimenopause Let's talk about GLP-1 medications the context of and menopause, because this is where the conversation most often gets flattened into something it is not. This is not about vanity GLP-1 Medications and Their Role

DOI: 10.1093/hropen/hoag015 When drugs meet disease: disentangling diabetes, obesity, and periconceptional GLP-1 receptor agonist safety by Yeyi Zhu and Monique M Hedderson, 18 March 2026, Human Reproduction Open

1 Click here to subscribe to Spencer Fane communications to ensure you receive timely updates like this directly in your inbox.

Going above and beyond to bring advanced science to skincare, skin technology brand NIOD continues its Copper Peptide franchise with Copper Amino Isolate Lipid 1% (CAIL)

Rodgers, Myostatin Attenuation In Vivo Reduces Adiposity, but Activates Adipogenesis, Endocrinology, vol

142 Further analyses of patients with severe albuminuria demonstrated comparable albuminuria-reducing effects between CCBs and ARB/ACEI